General MedicationsINTRAVENOUSStandard
AMMONIA N 13
AMMONIA N-13
Standard Dose
3.75mCi-260mCi/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview AMMONIA N 13 is listed in Drugs@FDA under application 215083 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient AMMONIA N-13 Form and strength INJECTABLE;INTRAVENOUS - 3.75mCi-260mCi/ML Sponsor METHODIST Submission history Latest submission status date: 2021-07-09 00:00:00.
Structured Monograph
Clinical summary
Approval overview AMMONIA N 13 is listed in Drugs@FDA under application 215083 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient AMMONIA N-13 Form and strength INJECTABLE;INTRAVENOUS - 3.75mCi-260mCi/ML Sponsor METHODIST Submission history Latest submission status date: 2021-07-09 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.